These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 864489)

  • 21. Pyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarction.
    Harano Y; Adair R; Vignos PJ; Miller M; Kowal J
    Metabolism; 1973 Mar; 22(3):493-501. PubMed ID: 4690655
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum pyruvate kinase in muscle disease and carrier states.
    Alberts MC; Samaha FJ
    Neurology; 1974 May; 24(5):462-4. PubMed ID: 4857105
    [No Abstract]   [Full Text] [Related]  

  • 23. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on genetic heterogeneity in Duchenne muscular dystrophy.
    Rabbi-Bortolini E; Zatz M
    Am J Med Genet; 1986 May; 24(1):111-7. PubMed ID: 3706399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Passos-Bueno MR; Bortolini ER; Pavanello Rde C; Peres CA
    J Neurol Sci; 1991 Apr; 102(2):190-6. PubMed ID: 2072118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophies.
    Zatz M; Shapiro LJ; Campion DS; Oda E; Kaback MM
    J Neurol Sci; 1978 May; 36(3):349-62. PubMed ID: 681967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 30. Myoglobinemia in Duchenne muscular dystrophy carriers.
    Ando T; Kato T; Ohsawa M; Fukuyama Y
    Brain Dev; 1980; 2(1):87-8. PubMed ID: 7416442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 32. Racial effect on serum creatine-kinase: implications for estimation of heterozygosity risks for females at-risk for Duchenne dystrophy.
    Passos-Bueno MR; Rabbi-Bortolini E; Azevêdo E; Zatz M
    Clin Chim Acta; 1989 Feb; 179(2):163-8. PubMed ID: 2920447
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma pyruvate kinase and creatine kinase activity in Becker muscular dystrophy.
    Aston JP; Kingston HM; Ramasamy I; Walters EG; Stansbie D
    J Neurol Sci; 1984 Sep; 65(3):307-14. PubMed ID: 6491692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum LDH-5 in carriers of Duchenne muscular dystrophy.
    Burt D; Emery AE
    Neurology; 1979 Feb; 29(2):239-41. PubMed ID: 571069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: pyruvate kinase isoenzymes and creatine phosphokinase in serum and blood cells.
    Smith I; Thomson WH
    Clin Chim Acta; 1977 Aug; 78(3):439-51. PubMed ID: 884869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum myoglobin in muscular dystrophy and carrier detection.
    Nicholson LV
    J Neurol Sci; 1981 Sep; 51(3):411-26. PubMed ID: 7276986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carrier assessment for mothers and sisters of isolated Duchenne dystrophy cases: the importance of serum enzyme determinations.
    Hyser CL; Doherty RA; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM
    Neurology; 1987 Sep; 37(9):1476-80. PubMed ID: 2888052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.